Home / Latest Reports / Visceral Pain Market

Visceral Pain Market by Product Type and End User- Global Industry Analysis & Forecast to 2027

Published On : August 2019 Pages : 166 Category: Pharma & Healthcare Report Code : HC085180

SEGMENTS & REGIONS:

  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Visceral Pain Market by Product Type (Pain Modifiers, Analgesics) End User (Irritable Bowel, Interstitial Cystitis, Others) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The visceral pain market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Visceral pain is the torment that arises from inner organs, such as stomach, bladder, uterus, or rectum. Basic models incorporate chest torment and practical stomach torment. In palliative drug, surely understood instinctive agony disorders incorporate torment from pancreatic disease and bowel obstruction. Ongoing advances have expanded comprehension of the symptomatic difficulties and restorative conceivable outcomes for patients with visceral pain syndromes.

Drivers and Restraints

Growing prevalence of visceral pain drives the growth of visceral pain market. Increasing activities by researchers and analysts in considering the torment starting from inside organs has reflected in the awareness of the significance of instinctive torment in patients. Furthermore, government’s initiatives propels the growth of visceral pain market. Rising collaboration within pharmaceutical companies provides beneficial opportunities for the visceral pain market. Increasing geriatric population and health awareness fuels the growth of visceral pain market.

Regional Insights

Among the geographies, North America is expected to dominate the visceral pain market. Rapid growth in healthcare industry in the region contribute to the growth of visceral pain market.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Addex Therapeutics Ltd
  • Pfizer Inc.
  • Grunenthal GmbH
  • Astellas Pharma Inc.
  • Neurim Pharmaceuticals Ltd
  • Chromocell Corporation
  • Medestea Research and Production S.p.A.
  • GIcare Pharma Inc

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   Visceral Pain Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)

o   Pain Modifiers

o   Analgesics

o   Visceral Pain Market, By End User, Estimates and Forecast, 2017-2027 ($Million)

o   Irritable Bowel

o   Interstitial Cystitis

o   Others

o   Visceral Pain Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o   Addex Therapeutics Ltd

o   Pfizer Inc.

o   Grunenthal GmbH

o   Astellas Pharma Inc.

o   Neurim Pharmaceuticals Ltd

o   Chromocell Corporation

o   Medestea Research and Production S.p.A.

o   GIcare Pharma Inc.

o   Visceral Pain Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o   North America

§  North America Visceral Pain Market , By Country

o   U.S. Visceral Pain Market

o   Canada Visceral Pain Market

o   Mexico Visceral Pain Market

o   Europe

§  Europe Visceral Pain Market , By Country

o   Germany Visceral Pain Market

o   UK Visceral Pain Market

o   France Visceral Pain Market

o   Russia Visceral Pain Market

o   Italy Visceral Pain Market

o   Rest of Europe Visceral Pain Market

o   Asia-Pacific

§  Asia-Pacific Visceral Pain Market , By Country

o   China Visceral Pain Market

o   Japan Visceral Pain Market

o   South Korea  Visceral Pain Market

o   India Visceral Pain Market

o   Southeast Asia Visceral Pain Market

o   Rest of Asia-Pacific Visceral Pain Market

o   South America

§  South America Visceral Pain Market , By Country

o   Brazil Visceral Pain Market

o   Argentina Visceral Pain Market

o   Columbia Visceral Pain Market

o   Rest of South America Visceral Pain Market

o   Middle East and Africa

§  Middle East and Africa Visceral Pain Market , By Country

o   Saudi Arabia Visceral Pain Market

o   UAE Visceral Pain Market

o   Egypt Visceral Pain Market

o   Nigeria Visceral Pain Market

o   South Africa Visceral Pain Market

o   Rest of MEA Visceral Pain Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Visceral Pain Market, By Product Type

5.1.     Introduction

5.2.     Global Visceral Pain Revenue and Market Share by Product Type (2017-2027)

5.2.1.  Global Visceral Pain Revenue and Revenue Share by Product Type (2017-2027)

5.3.     Pain Modifiers

5.3.1.  Global Pain Modifiers Revenue and Growth Rate (2017-2027)

5.4.     Analgesics

5.4.1.  Global Analgesics Revenue and Growth Rate (2017-2027)

6.       Visceral Pain Market, By End User

6.1.     Introduction

6.2.     Global Visceral Pain Revenue and Market Share by End User (2017-2027)

6.2.1.  Global Visceral Pain Revenue and Revenue Share by End User (2017-2027)

6.3.     Irritable Bowel

6.3.1.  Global Irritable Bowel Revenue and Growth Rate (2017-2027)

6.4.     Interstitial Cystitis

6.4.1.  Global Interstitial Cystitis Revenue and Growth Rate (2017-2027)

6.5.     Others

6.5.1.  Global Others Revenue and Growth Rate (2017-2027)

7.       Visceral Pain Market, By Region

7.1.     Introduction

7.2.     Global Visceral Pain Revenue and Market Share by Regions

7.2.1.  Global Visceral Pain Revenue by Regions (2017-2027)

7.3.     North America Visceral Pain by Countries

7.3.1.  North America Visceral Pain Revenue and Growth Rate (2017-2027)

7.3.2.  North America Visceral Pain Revenue (Million USD) by Countries (2017-2027)

7.3.3.  United States

7.3.3.1.  United States Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4.  Canada

7.3.4.1.  Canada Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5.  Mexico

7.3.5.1.  Mexico Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.     Europe Visceral Pain by Countries

7.4.1.  Europe Visceral Pain Revenue and Growth Rate (2017-2027)

7.4.2.  Europe Visceral Pain Revenue (Million USD) by Countries (2017-2027)

7.4.3.  Germany

7.4.3.1.  Germany Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4.  France

7.4.4.1.  France Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5.  UK

7.4.5.1.  UK Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  Russia

7.4.6.1.  Russia Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  Italy

7.4.7.1.  Italy Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.     Asia-Pacific Visceral Pain by Countries

7.5.1.  Asia-Pacific Visceral Pain Revenue and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Visceral Pain Revenue (Million USD) by Countries (2017-2027)

7.5.3.  China

7.5.3.1.  China Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4.  Japan

7.5.4.1.  Japan Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5.  Korea

7.5.5.1.  Korea Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  India

7.5.6.1.  India Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.     South America Visceral Pain by Countries

7.6.1.  South America Visceral Pain Revenue and Growth Rate (2017-2027)

7.6.2.  South America Visceral Pain Revenue (Million USD) by Countries (2017-2027)

7.6.3.  Brazil

7.6.3.1.  Brazil Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4.  Argentina

7.6.4.1.  Argentina Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5.  Columbia

7.6.5.1.  Columbia Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.     Middle East and Africa Visceral Pain by Countries

7.7.1.  Middle East and Africa Visceral Pain Revenue and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Visceral Pain Revenue (Million USD) by Countries (2017-2027)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5.  Egypt

7.7.5.1.  Egypt Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  South Africa

7.7.7.1.  South Africa Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Turkey

7.7.8.1.  Turkey Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.     Addex Therapeutics Ltd

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Pfizer Inc.

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Grunenthal GmbH

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Astellas Pharma Inc.

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     Neurim Pharmaceuticals Ltd

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Chromocell Corporation

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     Medestea Research and Production S.p.A.

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     GIcare Pharma Inc.

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

9.       Visceral Pain Market Forecast (2017-2027)

9.1.     Global Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2027)

9.2.     Visceral Pain Market Forecast by Regions (2017-2027)

9.2.1.  North America Visceral Pain Market Forecast (2017-2027)

9.2.1.1.  United States Visceral Pain Market Forecast (2017-2027)

9.2.1.2.  Canada Visceral Pain Market Forecast (2017-2027)

9.2.1.3.  Mexico Visceral Pain Market Forecast (2017-2027)

9.2.2.  Europe Visceral Pain Market Forecast (2017-2027)

9.2.2.1.  Germany Visceral Pain Market Forecast (2017-2027)

9.2.2.2.  France Visceral Pain Market Forecast (2017-2027)

9.2.2.3.  UK Visceral Pain Market Forecast (2017-2027)

9.2.2.4.  Russia Visceral Pain Market Forecast (2017-2027)

9.2.2.5.  Italy Visceral Pain Market Forecast (2017-2027)

9.2.2.6.  Rest of Europe Visceral Pain Market Forecast (2017-2027)

9.2.3.  Asia-Pacific Visceral Pain Market Forecast (2017-2027)

9.2.3.1.  China Visceral Pain Market Forecast (2017-2027)

9.2.3.2.  Japan Visceral Pain Market Forecast (2017-2027)

9.2.3.3.  Korea Visceral Pain Market Forecast (2017-2027)

9.2.3.4.  India Visceral Pain Market Forecast (2017-2027)

9.2.3.5.  Southeast Asia Visceral Pain Market Forecast (2017-2027)

9.2.3.6.  Rest of Asia-Pacific Visceral Pain Market Forecast (2017-2027)

9.2.4.  South America Visceral Pain Market Forecast (2017-2027)

9.2.4.1.  Brazil Visceral Pain Market Forecast (2017-2027)

9.2.4.2.  Argentina Visceral Pain Market Forecast (2017-2027)

9.2.4.3.  Columbia Visceral Pain Market Forecast (2017-2027)

9.2.4.4.  Rest of South America Visceral Pain Market Forecast (2017-2027)

9.2.5.  Middle East and Africa Visceral Pain Market Forecast (2017-2027)

9.2.5.1.  Saudi Arabia Visceral Pain Market Forecast (2017-2027)

9.2.5.2.  United Arab Emirates Visceral Pain Market Forecast (2017-2027)

9.2.5.3.  Egypt Visceral Pain Market Forecast (2017-2027)

9.2.5.4.  Nigeria Visceral Pain Market Forecast (2017-2027)

9.2.5.5.  South Africa Visceral Pain Market Forecast (2017-2027)

9.2.5.6.  Turkey Visceral Pain Market Forecast (2017-2027)

9.2.5.7.  Rest of Middle East and Africa Visceral Pain Market Forecast (2017-2027)

9.3.     Visceral Pain Market Forecast by Product Type (2017-2027)

9.3.1.  Visceral Pain Forecast by Product Type (2017-2027)

9.3.2.  Visceral Pain Market Share Forecast by Product Type (2017-2027)

9.4.     Visceral Pain Market Forecast by End User (2017-2027)

9.4.1.  Visceral Pain Forecast by End User (2017-2027)

9.4.2.  Visceral Pain Market Share Forecast by End User (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Visceral Pain Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Visceral Pain Revenue and Revenue Share by Product Type (2017-2018)
Figure Global Pain Modifiers Revenue and Growth Rate (2017-2018)
Figure Global Analgesics Revenue and Growth Rate (2017-2018)
Table Global Visceral Pain Revenue and Revenue Share by End User (2017-2018)
Figure Global Irritable Bowel Revenue and Growth Rate (2017-2018)
Figure Global Interstitial Cystitis Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Visceral Pain Revenue by Regions (2017-2018)
Figure North America Visceral Pain Growth Rate (2017-2018)
Figure North America Visceral Pain Revenue and Growth Rate (2017-2018)
Figure North America Visceral Pain by Countries (2017-2018)
Figure North America Visceral Pain Revenue (Million USD) by Countries (2017-2018)
Figure United States Visceral Pain Growth Rate (2017-2018)
Figure United States Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Visceral Pain Growth Rate (2017-2018)
Figure Canada Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Visceral Pain Growth Rate (2017-2018)
Figure Mexico Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Visceral Pain Growth Rate (2017-2018)
Figure Europe Visceral Pain Revenue and Growth Rate (2017-2018)
Figure Europe Visceral Pain by Countries (2017-2018)
Figure Europe Visceral Pain Revenue (Million USD) by Countries (2017-2018)
Figure Germany Visceral Pain Growth Rate (2017-2018)
Figure Germany Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Visceral Pain Growth Rate (2017-2018)
Figure France Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Visceral Pain Growth Rate (2017-2018)
Figure UK Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Visceral Pain Growth Rate (2017-2018)
Figure Russia Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Visceral Pain Growth Rate (2017-2018)
Figure Italy Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Visceral Pain Growth Rate (2017-2018)
Figure Rest of Europe Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Visceral Pain Growth Rate (2017-2018)
Figure Asia-Pacific Visceral Pain Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Visceral Pain by Countries (2017-2018)
Figure Asia-Pacific Visceral Pain Revenue (Million USD) by Countries (2017-2018)
Figure China Visceral Pain Growth Rate (2017-2018)
Figure China Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Visceral Pain Growth Rate (2017-2018)
Figure Japan Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Visceral Pain Growth Rate (2017-2018)
Figure Korea Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Visceral Pain Growth Rate (2017-2018)
Figure India Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Visceral Pain Growth Rate (2017-2018)
Figure Southeast Asia Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Visceral Pain Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Visceral Pain Growth Rate (2017-2018)
Figure South America Visceral Pain Revenue and Growth Rate (2017-2018)
Figure South America Visceral Pain by Countries (2017-2018)
Figure South America Visceral Pain Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Visceral Pain Growth Rate (2017-2018)
Figure Brazil Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Visceral Pain Growth Rate (2017-2018)
Figure Argentina Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Visceral Pain Growth Rate (2017-2018)
Figure Columbia Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Visceral Pain Growth Rate (2017-2018)
Figure Rest of South America Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Visceral Pain Growth Rate (2017-2018)
Figure Middle East and Africa Visceral Pain Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Visceral Pain by Countries (2017-2018)
Figure Middle East and Africa Visceral Pain Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Visceral Pain Growth Rate (2017-2018)
Figure Saudi Arabia Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Visceral Pain Growth Rate (2017-2018)
Figure United Arab Emirates Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Visceral Pain Growth Rate (2017-2018)
Figure Egypt Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Visceral Pain Growth Rate (2017-2018)
Figure Nigeria Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Visceral Pain Growth Rate (2017-2018)
Figure South Africa Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Visceral Pain Growth Rate (2017-2018)
Figure Turkey Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Visceral Pain Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Visceral Pain Revenue (Millions USD) and Growth Rate (2017-2018)
Table Addex Therapeutics Ltd Visceral Pain Financial Overview
Table Pfizer Inc. Visceral Pain Financial Overview
Table Grunenthal GmbH Visceral Pain Financial Overview
Table Astellas Pharma Inc. Visceral Pain Financial Overview
Table Neurim Pharmaceuticals Ltd Visceral Pain Financial Overview
Table Chromocell Corporation Visceral Pain Financial Overview
Table Medestea Research and Production S.p.A. Visceral Pain Financial Overview
Table GIcare Pharma Inc. Visceral Pain Financial Overview
Figure Global Visceral Pain Revenue (Millions USD) and Growth Rate (2018-2025)
Table Visceral Pain Market Forecast by Regions (2018-2025)
Figure North America Visceral Pain Market Forecast (2018-2025)
Figure United States Visceral Pain Market Forecast (2018-2025)
Figure Canada Visceral Pain Market Forecast (2018-2025)
Figure Mexico Visceral Pain Market Forecast (2018-2025)
Figure Europe Visceral Pain Market Forecast (2018-2025)
Figure Germany Visceral Pain Market Forecast (2018-2025)
Figure France Visceral Pain Market Forecast (2018-2025)
Figure UK Visceral Pain Market Forecast (2018-2025)
Figure Russia Visceral Pain Market Forecast (2018-2025)
Figure Italy Visceral Pain Market Forecast (2018-2025)
Figure Rest of Europe Visceral Pain Market Forecast (2018-2025)
Figure Asia-Pacific Visceral Pain Market Forecast (2018-2025)
Figure China Visceral Pain Market Forecast (2018-2025)
Figure Japan Visceral Pain Market Forecast (2018-2025)
Figure Korea Visceral Pain Market Forecast (2018-2025)
Figure India Visceral Pain Market Forecast (2018-2025)
Figure Southeast Asia Visceral Pain Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Visceral Pain Market Forecast (2018-2025)
Figure South America Visceral Pain Market Forecast (2018-2025)
Figure Brazil Visceral Pain Market Forecast (2018-2025)
Figure Argentina Visceral Pain Market Forecast (2018-2025)
Figure Columbia Visceral Pain Market Forecast (2018-2025)
Figure Rest of South America Visceral Pain Market Forecast (2018-2025)
Figure Middle East and Africa Visceral Pain Market Forecast (2018-2025)
Figure Saudi Arabia Visceral Pain Market Forecast (2018-2025)
Figure United Arab Emirates Visceral Pain Market Forecast (2018-2025)
Figure Egypt Visceral Pain Market Forecast (2018-2025)
Figure Nigeria Visceral Pain Market Forecast (2018-2025)
Figure South Africa Visceral Pain Market Forecast (2018-2025)
Figure Turkey Visceral Pain Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Visceral Pain Market Forecast (2018-2025)
Figure Global Visceral Pain Forecast by Product Type (2018-2025)
Figure Global Visceral Pain Market Share Forecast by Product Type (2018-2025)
Figure Global Visceral Pain Forecast by Product Type (2018-2025)
Figure Global Visceral Pain Forecast by End User (2018-2025)
Figure Global Visceral Pain Market Share Forecast by End User (2018-2025)
Figure Global Visceral Pain Forecast by End User (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

Request Sample Enquire Before Buying Request for Customization

Request Sample